Introduction to End-of-Life Symptom Management

Managing terminal symptoms effectively remains a cornerstone of high-quality hospital care. Clinicians frequently utilize continuous palliative sedation (CPS) and continuous opioid infusion (COI) to alleviate refractory suffering. However, a recent retrospective study highlights a concerning prevalence of deviations from continuous palliative sedation guidelines. These deviations often occur in acute hospital settings, potentially compromising the quality of end-of-life care for vulnerable patients.

Analyzing Study Findings on Guideline Deviations

The evaluation analyzed 101 patients receiving CPS and 129 patients receiving COI. Researchers identified clinically relevant guideline deviations in 52.5% of the CPS cohort. These issues primarily involved inappropriate changes in opioid dosages during the sedation process. Even more strikingly, 76.7% of patients on COI experienced at least one guideline deviation. Specifically, these errors related to incorrect starting doses and the unsafe use of morphine in patients with impaired renal function. Consequently, such findings suggest that standard hospital protocols may not always align with specialist recommendations.

The Role of Specialized Palliative Teams

One significant observation from the data is the positive impact of multidisciplinary involvement. When the palliative consulting team or the pain management team participated in care, the frequency of guideline deviations decreased. Specialist teams provide essential expertise in titration and toxicity monitoring. Furthermore, their involvement ensures that medications are adjusted according to the patient’s metabolic state, such as renal clearance. This evidence underscores the necessity of integrating specialized palliative services early in the terminal phase.

Implementing Continuous Palliative Sedation Guidelines in Practice

To improve clinical compliance, hospitals should prioritize robust training for internal medicine and critical care staff. Education must focus on the nuances of opioid conversion and the specific risks of metabolite accumulation in renal failure. Moreover, clinicians must strictly adhere to continuous palliative sedation guidelines to avoid the double-effect risks or sub-optimal symptom control. Implementing standardized checklists and early consultation triggers can further bridge the gap between current practice and national benchmarks.

FAQs

What are the most common errors in continuous opioid infusion?

Common errors include incorrect initial dosing and failure to adjust opioid types for patients with impaired renal function, which can lead to neurotoxicity.

Why is specialist involvement crucial in palliative sedation?

Specialized palliative teams offer expertise in complex titration and symptom assessment, which significantly reduces deviations from established clinical guidelines and improves patient comfort.

How can hospitals reduce deviations from palliative care protocols?

Hospitals can reduce deviations by providing targeted staff training, utilizing standardized order sets, and ensuring early referral to palliative care specialists for terminal symptom management.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.

References

1. Gulikers JL et al. Retrospective Evaluation of the Use of Continuous Palliative Sedation and Continuous Opioid Infusion in Hospitalized Patients in End-Of-Life Care. Am J Hosp Palliat Care. 2026 Mar 30. doi: 10.1177/10499091261439121. PMID: 41906964.


2. Indian Association of Palliative Care (IAPC). End of Life Care Policy for the Dying: Consensus Position Statement of Indian Association of Palliative Care. Indian J Palliat Care. 2014.


3. National Cancer Grid (NCG). Palliative Care Guidelines – End of Life Care. Released May 2021.